Company name
2022Founder
Ashley N. Abel leads Metri Bio, which develops therapies for endometrial conditions, with a current focus on endometriosis. She trained in genetics at Yale, where her research on differences between human and mouse biology helped shape the company’s interest in human-tissue models; she has also co-authored research on endometrial modeling.
Chief Executive Officer, Co-Founder
Bachelor's studies in biology
Cosign details are not available yet.
More profile details are not available yet.